## Clinical Assessment and Management of Mitral Stenosis **Key Point:** Mitral stenosis is a progressive valvular lesion requiring careful hemodynamic assessment and individualized management based on symptom severity, valve anatomy, and rhythm status. ### Echocardiographic Assessment **High-Yield:** Echocardiography is the gold standard for diagnosing and assessing severity of MS: - **Transthoracic echo (TTE):** First-line imaging, adequate for most patients - **Transesophageal echo (TEE):** Superior image quality, especially for: - Assessing leaflet morphology and calcification - Detecting left atrial thrombus - Evaluating suitability for percutaneous mitral commissurotomy (PMC) - Guiding the procedure itself **Clinical Pearl:** TEE is essential before PMC because it helps identify patients with unfavorable anatomy (heavy calcification, subvalvular disease, LA thrombus) who are at higher risk of complications. ### Auscultatory Findings and Maneuvers **Mnemonic:** **MS MURMUR = DECREASES with amyl nitrite** (reduces afterload → decreases LA pressure → shorter murmur) The diastolic murmur of mitral stenosis: - **Decreases** with amyl nitrite (reduces afterload and LA pressure) - **Increases** with leg raise or handgrip (increases preload and LA pressure) - **Increases** with exercise or any increase in cardiac output **Key Point:** Amyl nitrite causes peripheral vasodilation and reduced afterload, which decreases LA pressure and shortens the diastolic murmur duration. This is the OPPOSITE of what occurs in mitral regurgitation (where the systolic murmur increases with amyl nitrite). ### Hemodynamic Assessment: Cardiac Catheterization Catheterization can directly measure: - Transmitral pressure gradient (difference between LA and LV diastolic pressures) - Mitral valve area using the **Gorlin formula**: $$MVA = \frac{\text{Cardiac Output}}{\text{Heart Rate} \times \text{Diastolic Filling Period} \times \text{Mean Pressure Gradient}}$$ **Clinical Pearl:** Catheterization is now rarely needed for diagnosis (echo suffices) but remains useful for: - Assessing coronary artery disease before surgery - Hemodynamic assessment when echo is inconclusive - Performing PMC (therapeutic catheterization) ### Anticoagulation Strategy in Mitral Stenosis **High-Yield:** Anticoagulation is NOT indicated in all MS patients. The indication depends on rhythm status: | Rhythm Status | Anticoagulation Indicated? | Rationale | |---|---|---| | Sinus rhythm, no LA thrombus | NO | Low thromboembolic risk in sinus rhythm | | Atrial fibrillation | YES | High thromboembolic risk; warfarin or DOAC | | History of thromboembolism | YES | Regardless of rhythm; secondary prevention | | TEE-documented LA thrombus | YES | Direct evidence of thrombosis | **Key Point:** Anticoagulation is indicated for: 1. Atrial fibrillation (most common indication in MS) 2. Previous thromboembolism 3. LA thrombus on imaging It is NOT routinely indicated in patients with mitral stenosis in sinus rhythm without prior embolism. **Clinical Pearl:** The presence of AF in MS dramatically increases thromboembolic risk (up to 10–15% per year without anticoagulation), making AF detection and anticoagulation a critical part of MS management. ## Why Option 3 Is Incorrect Anticoagulation is NOT indicated in all MS patients. It is specifically indicated in: - Atrial fibrillation - Prior thromboembolism - LA thrombus Patients in sinus rhythm without prior embolism do not routinely require anticoagulation, even if they have significant MS. This is a common misconception and a frequent exam trap. ### Management Algorithm for Mitral Stenosis ```mermaid flowchart TD A[Mitral Stenosis Diagnosed]:::outcome --> B{Symptoms?}:::decision B -->|No symptoms| C{Severe MS?}:::decision B -->|Symptomatic| D[Intervention indicated]:::action C -->|MVA < 1.5 cm²| E[Monitor closely, activity restriction]:::action C -->|MVA ≥ 1.5 cm²| F[Conservative management]:::action D --> G{AF present?}:::decision G -->|Yes| H[Anticoagulation + Rate control]:::action G -->|No| I{LA thrombus?}:::decision I -->|Yes| J[Anticoagulation]:::action I -->|No| K[PMC or Surgery]:::action H --> K J --> K ``` **High-Yield:** The decision for intervention (PMC vs. surgery) depends on: - Symptom severity - Valve anatomy (Wilkins score) - Presence of contraindications (LA thrombus, severe MR, subvalvular disease) - Patient factors (age, pregnancy plans, renal function)
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.